저침습 수술 기기 시장 - 규모, 점유율, 성장률, 산업 분석 : 유형별, 용도별, 지역별 인사이트 및 예측(2026-2034년)

Growth Factors of minimally invasive surgery (MIS) devices Market

The global minimally invasive surgery (MIS) devices market is experiencing robust growth due to the rising preference for less traumatic surgical procedures and continuous technological advancements. According to Fortune Business Insights, the market was valued at USD 20.27 billion in 2025 and is projected to grow to USD 21.61 billion in 2026. By 2034, the market is expected to reach USD 41.41 billion, registering a CAGR of 8.47% during the forecast period (2026-2034). North America dominated the market in 2025 with a share of 43.18%, supported by advanced healthcare infrastructure, high surgical volumes, and favorable reimbursement policies.

Market Overview

Minimally invasive surgery devices are specialized medical instruments used to perform surgical procedures through small incisions or natural body openings. These devices include endoscopic devices, laparoscopic instruments, robotic-assisted systems, guiding devices, inflation devices, and navigation & visualization systems. MIS procedures offer significant advantages over traditional open surgeries, including reduced blood loss, minimal scarring, lower infection risk, shorter hospital stays, and faster patient recovery.

The growing preference for minimally invasive approaches among both patients and healthcare providers is driving widespread adoption across multiple surgical disciplines, including orthopedics, cardiology, gynecology, gastrointestinal surgery, and neurology.

Market Drivers

The rising incidence of chronic diseases such as cardiovascular disorders, cancer, diabetes, and obesity is a major factor driving market growth. According to data published in January 2025, nearly 620 million people worldwide live with heart and circulatory diseases, many of whom require surgical intervention. Minimally invasive procedures are increasingly favored due to their ability to reduce postoperative complications and improve clinical outcomes.

Additionally, the increasing number of orthopedic and sports-related injuries is contributing to higher adoption of arthroscopic and minimally invasive orthopedic surgeries. As of 2025, over 4 million arthroscopic knee surgeries are performed annually worldwide, significantly boosting demand for MIS devices.

Market Restraints

Despite strong growth prospects, high costs associated with MIS devices remain a key restraint. Advanced technologies such as robotic surgical systems require substantial upfront investment, often exceeding USD 2.0 million per system, excluding maintenance and training costs. These high expenses limit adoption to large, well-funded hospitals and restrict penetration in rural and resource-limited healthcare settings.

Market Opportunities

The rapid expansion of ambulatory surgery centers (ASCs) presents a major growth opportunity. According to the Ambulatory Surgery Centers Association, over 6,300 Medicare-certified ASCs were operational in the U.S. as of 2024. ASCs increasingly adopt minimally invasive technologies due to their alignment with outpatient care models, cost efficiency, and favorable reimbursement structures. This shift is expected to sustain long-term demand for MIS devices.

Market Challenges

A significant challenge facing the market is the shortage of skilled surgical professionals trained in minimally invasive techniques. According to the American Association of Medical Colleges, the U.S. may face a shortage of up to 30,200 surgeons by 2036. Limited access to specialized training, particularly in developing regions, hampers the widespread adoption of MIS procedures and devices.

Market Trends

Continuous technological advancements are reshaping the MIS landscape. Robotic-assisted surgical systems, AI-powered navigation tools, 3D imaging, and miniaturized instruments are enhancing surgical precision and outcomes. Single-port laparoscopic and natural orifice surgeries are gaining popularity due to reduced scarring and faster recovery, further fueling demand for advanced MIS devices.

Segmentation Insights

• By Type: Endoscopic devices dominated the market in 2024 due to increased use in endovascular procedures. Robotic-assisted surgery devices are expected to grow at the fastest CAGR.
• By Application: The orthopedic segment led the market in 2024, driven by rising fractures and joint disorders, followed by cardiology and gastrointestinal applications.
• By End User: Hospitals & ASCs held the largest share due to advanced infrastructure and higher surgical volumes.

Regional Analysis

North America accounted for USD 8.75 billion in 2025, with the U.S. market expected to reach USD 8.81 billion by 2026.

Europe remains a strong contributor, supported by robotic surgery adoption, with Germany projected to reach USD 1.35 billion by 2026.

Asia Pacific is expected to grow at the fastest rate, driven by aging populations and rising healthcare investments. By 2026, China is projected at USD 1.79 billion, Japan at USD 1.38 billion, and India at USD 0.37 billion.

Competitive Landscape

The market is consolidated, with key players such as Medtronic, Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Boston Scientific, Olympus, Stryker, B. Braun, and Intuitive Surgical. These companies focus on product innovation, strategic collaborations, and geographic expansion to strengthen their market presence.

Conclusion

The global minimally invasive surgery devices market is poised for strong expansion, growing from USD 20.27 billion in 2025 to USD 41.41 billion by 2034. Increasing prevalence of chronic diseases, rising adoption of outpatient surgical procedures, and continuous technological innovation are driving market growth. While high costs and workforce shortages remain challenges, expanding ambulatory care infrastructure and advancements in robotic and AI-assisted technologies are expected to shape the future of minimally invasive surgery worldwide.

Segmentation By Type

• Inflation Devices
• Guiding Devices
• Endoscopic Devices
• Laparoscopic Devices
• Robotic Assistive Surgery Devices
• Navigation & Visualization Systems
• Others

By Application

• Cardiology
• Gastrointestinal
• Orthopedic
• Gynecological
• Neurology
• Dental
• Others

By End-user

• Hospitals & ASCs
• Clinics
• Others

By Geography

• North America (By Type, Application, End-user, and Country)
  • U.S.
  • Canada
• Europe (By Type, Application, End-user, and Country/Sub-region)
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific (By Type, Application, End-user, and Country/Sub-region)
  • China
  • Japan
  • India
  • Australia
  • Rest of Asia Pacific
• Latin America (By Type, Application, End-user, and Country/Sub-region)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (By Type, Application, End-user, and Country/Sub-region)
  • GCC
  • South Africa
  • Middle East & Africa

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Number of Key Surgeries, By Key Countries/Region, 2025
• 4.2. Key Industry Developments - (Mergers, Acquisition & Partnerships, etc.)
• 4.3. Overview: Regulatory & Reimbursement Scenario
• 4.4. New Product Launches, By Key Players

5. Global Minimally Invasive Surgery Devices Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Type
  • 5.1.1. Inflation Devices
  • 5.1.2. Guiding Devices
  • 5.1.3. Endoscopic Devices
  • 5.1.4. Laparoscopic Devices
  • 5.1.5. Robotic Assistive Surgery Devices
  • 5.1.6. Navigation & Visualization Systems
  • 5.1.7. Others
• 5.2. Market Analysis, Insights and Forecast - By Application
  • 5.2.1. Cardiology
  • 5.2.2. Gastrointestinal
  • 5.2.3. Orthopedic
  • 5.2.4. Gynecological
  • 5.2.5. Neurology
  • 5.2.6. Dental
  • 5.2.7. Others
• 5.3. Market Analysis, Insights and Forecast - By End-user
  • 5.3.1. Hospitals & ASCs
  • 5.3.2. Clinics
  • 5.3.3. Others
• 5.4. Market Analysis, Insights and Forecast - By Region
  • 5.4.1. North America
  • 5.4.2. Europe
  • 5.4.3. Asia Pacific
  • 5.4.4. Latin America
  • 5.4.5. Middle East & Africa

6. North America Minimally Invasive Surgery Devices Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Type
  • 6.1.1. Inflation Devices
  • 6.1.2. Guiding Devices
  • 6.1.3. Endoscopic Devices
  • 6.1.4. Laparoscopic Devices
  • 6.1.5. Robotic Assistive Surgery Devices
  • 6.1.6. Navigation & Visualization Systems
  • 6.1.7. Others
• 6.2. Market Analysis, Insights and Forecast - By Application
  • 6.2.1. Cardiology
  • 6.2.2. Gastrointestinal
  • 6.2.3. Orthopedic
  • 6.2.4. Gynecological
  • 6.2.5. Neurology
  • 6.2.6. Dental
  • 6.2.7. Others
• 6.3. Market Analysis, Insights and Forecast - By End-user
  • 6.3.1. Hospitals & ASCs
  • 6.3.2. Clinics
  • 6.3.3. Others
• 6.4. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 6.4.1. U.S.
  • 6.4.2. Canada

7. Europe Minimally Invasive Surgery Devices Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Type
  • 7.1.1. Inflation Devices
  • 7.1.2. Guiding Devices
  • 7.1.3. Endoscopic Devices
  • 7.1.4. Laparoscopic Devices
  • 7.1.5. Robotic Assistive Surgery Devices
  • 7.1.6. Navigation & Visualization Systems
  • 7.1.7. Others
• 7.2. Market Analysis, Insights and Forecast - By Application
  • 7.2.1. Cardiology
  • 7.2.2. Gastrointestinal
  • 7.2.3. Orthopedic
  • 7.2.4. Gynecological
  • 7.2.5. Neurology
  • 7.2.6. Dental
  • 7.2.7. Others
• 7.3. Market Analysis, Insights and Forecast - By End-user
  • 7.3.1. Hospitals & ASCs
  • 7.3.2. Clinics
  • 7.3.3. Others
• 7.4. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 7.4.1. U.K.
  • 7.4.2. Germany
  • 7.4.3. France
  • 7.4.4. Spain
  • 7.4.5. Italy
  • 7.4.6. Scandinavia
  • 7.4.7. Rest of Europe

8. Asia pacific Minimally Invasive Surgery Devices Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Type
  • 8.1.1. Inflation Devices
  • 8.1.2. Guiding Devices
  • 8.1.3. Endoscopic Devices
  • 8.1.4. Laparoscopic Devices
  • 8.1.5. Robotic Assistive Surgery Devices
  • 8.1.6. Navigation & Visualization Systems
  • 8.1.7. Others
• 8.2. Market Analysis, Insights and Forecast - By Application
  • 8.2.1. Cardiology
  • 8.2.2. Gastrointestinal
  • 8.2.3. Orthopedic
  • 8.2.4. Gynecological
  • 8.2.5. Neurology
  • 8.2.6. Dental
  • 8.2.7. Others
• 8.3. Market Analysis, Insights and Forecast - By End-user
  • 8.3.1. Hospitals & ASCs
  • 8.3.2. Clinics
  • 8.3.3. Others
• 8.4. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 8.4.1. Japan
  • 8.4.2. China
  • 8.4.3. India
  • 8.4.4. Australia
  • 8.4.5. Southeast Asia
  • 8.4.6. Rest of Asia Pacific

9. Latin America Minimally Invasive Surgery Devices Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Type
  • 9.1.1. Inflation Devices
  • 9.1.2. Guiding Devices
  • 9.1.3. Endoscopic Devices
  • 9.1.4. Laparoscopic Devices
  • 9.1.5. Robotic Assistive Surgery Devices
  • 9.1.6. Navigation & Visualization Systems
  • 9.1.7. Others
• 9.2. Market Analysis, Insights and Forecast - By Application
  • 9.2.1. Cardiology
  • 9.2.2. Gastrointestinal
  • 9.2.3. Orthopedic
  • 9.2.4. Gynecological
  • 9.2.5. Neurology
  • 9.2.6. Dental
  • 9.2.7. Others
• 9.3. Market Analysis, Insights and Forecast - By End-user
  • 9.3.1. Hospitals & ASCs
  • 9.3.2. Clinics
  • 9.3.3. Others
• 9.4. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 9.4.1. Brazil
  • 9.4.2. Mexico
  • 9.4.3. Rest of Latin America

10. Middle East & Africa Minimally Invasive Surgery Devices Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Type
  • 10.1.1. Inflation Devices
  • 10.1.2. Guiding Devices
  • 10.1.3. Endoscopic Devices
  • 10.1.4. Laparoscopic Devices
  • 10.1.5. Robotic Assistive Surgery Devices
  • 10.1.6. Navigation & Visualization Systems
  • 10.1.7. Others
• 10.2. Market Analysis, Insights and Forecast - By Application
  • 10.2.1. Cardiology
  • 10.2.2. Gastrointestinal
  • 10.2.3. Orthopedic
  • 10.2.4. Gynecological
  • 10.2.5. Neurology
  • 10.2.6. Dental
  • 10.2.7. Others
• 10.3. Market Analysis, Insights and Forecast - By End-user
  • 10.3.1. Hospitals & ASCs
  • 10.3.2. Clinics
  • 10.3.3. Others
• 10.4. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 10.4.1. GCC
  • 10.4.2. South Africa
  • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles
  • 11.2.1. Medtronic
    • 11.2.1.1. Overview
    • 11.2.1.2. Products
    • 11.2.1.3. SWOT Analysis
    • 11.2.1.4. Recent Developments
    • 11.2.1.5. Strategies
    • 11.2.1.6. Financials (Based on Availability)
  • 11.2.2. Johnson & Johnson Services, Inc.
    • 11.2.2.1. Overview
    • 11.2.2.2. Products
    • 11.2.2.3. SWOT Analysis
    • 11.2.2.4. Recent Developments
    • 11.2.2.5. Strategies
    • 11.2.2.6. Financials (Based on Availability)
  • 11.2.3. Koninklijke Philips N.V.
    • 11.2.3.1. Overview
    • 11.2.3.2. Products
    • 11.2.3.3. SWOT Analysis
    • 11.2.3.4. Recent Developments
    • 11.2.3.5. Strategies
    • 11.2.3.6. Financials (Based on Availability)
  • 11.2.4. Boston Scientific Corporation
    • 11.2.4.1. Overview
    • 11.2.4.2. Products
    • 11.2.4.3. SWOT Analysis
    • 11.2.4.4. Recent Developments
    • 11.2.4.5. Strategies
    • 11.2.4.6. Financials (Based on Availability)
  • 11.2.5. Olympus Corporation
    • 11.2.5.1. Overview
    • 11.2.5.2. Products
    • 11.2.5.3. SWOT Analysis
    • 11.2.5.4. Recent Developments
    • 11.2.5.5. Strategies
    • 11.2.5.6. Financials (Based on Availability)
  • 11.2.6. Stryker
    • 11.2.6.1. Overview
    • 11.2.6.2. Products
    • 11.2.6.3. SWOT Analysis
    • 11.2.6.4. Recent Developments
    • 11.2.6.5. Strategies
    • 11.2.6.6. Financials (Based on Availability)
  • 11.2.7. B. Braun SE
    • 11.2.7.1. Overview
    • 11.2.7.2. Products
    • 11.2.7.3. SWOT Analysis
    • 11.2.7.4. Recent Developments
    • 11.2.7.5. Strategies
    • 11.2.7.6. Financials (Based on Availability)
  • 11.2.8. Steris
    • 11.2.8.1. Overview
    • 11.2.8.2. Products
    • 11.2.8.3. SWOT Analysis
    • 11.2.8.4. Recent Developments
    • 11.2.8.5. Strategies
    • 11.2.8.6. Financials (Based on Availability)
  • 11.2.9. Intuitive Surgical
    • 11.2.9.1. Overview
    • 11.2.9.2. Products
    • 11.2.9.3. SWOT Analysis
    • 11.2.9.4. Recent Developments
    • 11.2.9.5. Strategies
    • 11.2.9.6. Financials (Based on Availability)